Skip to main content

Table 2 Baseline characteristics of study participants; cases, controls, and combined sample

From: The blood microbiome and its association to cardiovascular disease mortality: case-cohort study

Variable

Cases

n = 227

Controls

n = 178

Combined sample

n = 405

t-test/Fisher test p-value (2-sided)

Age at entry, mean (SD) years

71.3 (2.0)

71.2 (2.7)

71.3 (2.4)

0.755

Age at exit, mean (SD) years

76.9 (3.5)

80.2 (3.2)

78.4 (3.7)

0.568

Diabetes, yes

38 (17.3%)

12 (6.8%)

50 (12.6%)

0.002

Use antihypertensive medication, yes

117 (53.2%)

42 (25.0%)

159 (41.0%)

 < 0.001

History of myocardial infarction, yes

66 (29.7%)

18 (10.1%)

84 (21.0%)

 < 0.001

History of heart failure, yes

20 (9.1%)

8 (4.7%)

28 (7.2%)

0.114

Systolic blood pressure, mean (SD) mmHg

151.0 (22.2)

145.0 (20.5)

148.4 (21.7)

0.253

Subjective health, bad

13 (5.8%)

5 (2.8%)

18 (4.5%)

0.224

Physical activity, no hard activity

125 (58.7%)

70 (43.5%)

195 (52.1%)

0.002

Excessive coffee consumption, > 3 cups per day

91 (40.4%)

54 (31.2%)

145 (36.4%)

0.047

  1. Nine years follow-up of the Oslo II study from 2000